Cardiovascular Safety Results of INP104 (POD-DHE) from the STOP 301 Phase 3 Study (2493)
Year: 2021
Type: article
Source: Neurology
Authors: Karen Craig, John Hoekman, Maria Jeleva, Jasna Hocevar-Trnka, Sheena K. Aurora, Stephen Shrewsbury
Institution: Impel Neuropharma (United States)
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389449047
